Tag Archive: Events

  1. TERMIS-EU Workshop: 3D Bioprinting in Cancer Research

    Leave a Comment

    Biogelx will be at the upcoming TERMIS-EU Workshop focused on 3D Bioprinting in Cancer Research. The conference will take place in Nantes, France on August 26-27, 2019. The event offers an amazing opportunity to learn about the latest advances in 3D Bioprinting as it relates to specific applications in advanced 3D in-vitro models for cancer research.

    We will be presenting our new Biogelx-INKs which we launched earlier this year. Come say hi and discover our latest bioprinting innovation, we’d love to meet you!

    Scientific sessions from top experts in the field will cover all aspects of bioprinting in cancer research. You can take a look at the amazing program at workshop-termis.eu website or can download from here.

    If you’d like to speak with us, come find Elia during the conference, or schedule a time to speak with us in advance by emailing us now!

    In the meantime, you might want to read what we have been writing about cancer research and bioprinting in the past:

    And in case you’d like to try our bioinks… We have a summer deal going on right now!

    30% OFF on BIOINKs Unlock Deal Now

  2. Novel 3D Biomaterials for use in Advanced Therapies

    Leave a Comment

    If you are interested in Advanced Therapies, please come join us in Barcelona on March 18, 2019 for a masterclass on “Advanced Therapies Research, Development and Collaboration”, organised by Advance (Cat)and the Cell and Gene Therapy Catapult (UK), in partnership with the UK Department for International Trade (DIT)and Creatio.

    This masterclass event offers the opportunity for you to hear Advanced Therapies experts cover crucial aspects necessary to go from research to clinical application and product development. Top experts from Spain and the UK will share their experience and we welcome an interactive session with lots of networking time in order to have the opportunity to meet with you.

    We will be presenting Biogelx technology as a tool that enables the generation of 3D cellular models for research applications in Advance Therapies. The possibility of utilizing Biogelx materials to model specific cellular/tissue environments provides a valuable tool for Stem Cell Therapyand Tissue Engineering.

    To attend please email usor register here.

    DETAILS:

    March 18, 2019, 15:00

    Aula Magna – Faculty of Medicine and Health Sciences (Universitat de Barcelona), C/ Casanova 143, Barcelona

  3. Biogelx peptide hydrogels: Bio-inspired materials for 3D cell culture and bioprinting

    1 Comment
    Listen to our 25-minute presentation, and explore Biogelx core technology with Dr. Chris Allan, Development Scientist.

    At Biogelx, we are helping people who work in translational science, drug discovery and tissue engineering by making in vitro cell cultures more in vivo. We do this through manufacturing and supplying 3D cell culture materials that can be tuned to specific tissues, and synthetic bio-inks that are reproducible and easy to handle. Our portfolio of biomaterials is comprised of synthetic peptide hydrogels that mimic the extracellular-matrix to support cell growth. In addition, the chemical and physical properties of our biomaterials can be precisely tuned to replicate the characteristics of specific tissues so that the cells experience and engage with a realistic 3D environment.

    Key Learning Objectives:

    • The advantages of Biogelx hydrogel technology
    • Biocompatibility is key: growing a wide range of cell types
    • Printing with peptide hydrogels: A case study of synthetic bio-ink development
    • Here to support you: Bio-ink formulation service

    Do you want to learn more? Watch our recent webinar on ‘The advantage of peptide hydrogels over other 3D cell culture matrices’. Click on the link below!

    The advantages of peptide hydrogels over other 3D cell culture matrices.

  4. Next stop is Europe’s biggest drug discovery congress

    Leave a Comment

    We are delighted to tell you that we are attending the World Preclinical Congress in Lisbon, Portugal on 27-30 November. The conference provides a unique opportunity for academia and pharma/biotech companies to exchange knowledge in early drug discovery and development.

    Unfortunately, the traditional drug development methods are still inefficient and expensive processes due to their high failure rate. There is evidence showing that species-specific differences limit the ability of animal models to predict human biological reactions. Thankfully, in the last few years, a new generation of 3D models have been developed as alternative in-vitro functional assays. Hereby, scientists can make progress towards predicting safety and efficacy screens that are more relatable to the clinic.

    We look forward to meeting the key players of the preclinical world and learn the scientific and technical advancements related to better optimize drug candidates and accurately predict drug-related toxicity.

    If you are visiting the event, please make sure to meet with us! Elia Lopez-Bernardo, PhD will be there for a chance to discuss our innovative technology and the applications of BiogelxTMproducts in preclinical drug discovery.

    If you want to secure time to speak with Elia, please click here and arrange a meeting.

     

    You might like:

    3D In-Vitro Tumor Models Are Changing Cancer Research and Drug Discovery

    How to mitigate the risk of low success rate in clinical trials

    Not all 3D Cultures are Created Equally – Which is the best one for you?

  5. The advantages of peptide hydrogels over other 3D cell culture matrices.

    3 Comments
    Watch the video now!

    Try Biogelx 3D Hydrogel Systems! Buy a Discovery Kit!

    To ensure you receive an invite to our next webinar, subscribe here!

    Cell culture is an essential tool for the study of cell biology and preclinical biomedical research and has become a vital component of drug screening and toxicity testing in pharmacology research. Over recent years it has been widely acknowledged that 3D cell culture techniques can provide more physiologically-relevant results to more traditional 2D culture systems.

    Cell culture models utilising 3D matrices allow individual cells to maintain their normal morphology, allow complex cell-cell and cell-matrix interactions, and provides oxygen and nutrient gradients, thereby providing an environment which more closely mimics the natural ECM, promoting the creation of native architecture found in vivo. Such matrices often take the form of hydrogels.

    Hydrogels are water-swollen networks of crosslinked polymeric chains (up to 99% water) and have emerged as the most promising option for cell culture since they mimic salient elements of native ECMs and possess mechanics similar to those of many soft tissues.

    In this context, both natural and synthetic hydrogels have been investigated extensively for the encapsulation and culture of cells, with both classes providing their own set of advantages and limitations. To achieve the best of both worlds, researchers are turning their attention to synthetic peptide hydrogels as 3D cell culture matrices where a balance of biocompatibility and consistency are possible.

    Watch this webinar and learn:

    • How our synthetic peptide hydrogels can provide a more physiologically relevant environment in vitro.
    • How our 3D hydrogels can be tailored to control cell behaviour
    • The potential of synthetic peptide hydrogels in applications including cancer research, cell-based assays, and regenerative medicine.
    Presented by

    Robert Edward Schwartz, M.D., Ph.D.

    Assistant Professor of Medicine at the Sanford I. Weill Medical College of Cornell University and an Attending Physician, New York-Presbyterian Hospital Cornell campus

    Professor Matthew Dalby

    Professor of Cell Engineering (Institute of Molecular Cell and Systems Biology) at the University of Glasgow

    Mitch Scanlan

    Chief Executive Officer of Biogelx Limited, former Sales & Marketing Director of Sartorius Stedim BioOutsource, and former Head of Sales & Marketing at Millipore UK

Biogelx